13.85
0.29 (2.14%)
| Previous Close | 13.56 |
| Open | 13.78 |
| Volume | 1,223,255 |
| Avg. Volume (3M) | 827,535 |
| Market Cap | 1,189,793,920 |
| Price / Earnings (Forward) | 7.94 |
| Price / Sales | 0.510 |
| Price / Book | 1.39 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2025 - 8 Aug 2025 |
| Profit Margin | -4.92% |
| Operating Margin (TTM) | 11.56% |
| Diluted EPS (TTM) | -1.19 |
| Quarterly Revenue Growth (YOY) | 1.20% |
| Quarterly Earnings Growth (YOY) | -9.10% |
| Total Debt/Equity (MRQ) | 86.58% |
| Current Ratio (MRQ) | 1.47 |
| Operating Cash Flow (TTM) | 206.57 M |
| Levered Free Cash Flow (TTM) | 173.92 M |
| Return on Assets (TTM) | 5.25% |
| Return on Equity (TTM) | -12.28% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Pediatrix Medical Group, Inc. | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.13 |
|
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment and generates majority of the revenue through neonatology and other pediatric subspecialties. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 1.78% |
| % Held by Institutions | 101.09% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Caspian Capital Lp | 30 Sep 2024 | 1,115,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 20.00 (Macquarie, 44.40%) | Buy |
| Median | 16.00 (15.52%) | |
| Low | 16.00 (UBS, 15.52%) | Hold |
| 16.00 (Truist Securities, 15.52%) | Hold | |
| Average | 17.33 (25.13%) | |
| Total | 1 Buy, 2 Hold | |
| Avg. Price @ Call | 14.05 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| UBS | 12 May 2025 | 16.00 (15.52%) | Hold | 14.36 |
| Macquarie | 08 May 2025 | 20.00 (44.40%) | Buy | 14.44 |
| Truist Securities | 11 Apr 2025 | 16.00 (15.52%) | Hold | 13.34 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 06 May 2025 | Announcement | Pediatrix Medical Group Reports First Quarter Results |
| 21 Apr 2025 | Announcement | Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |